Baxter International Inc (NYSE:BAX)

Delayed Data
As of 4:00pm ET
 -0.355 / -0.92%
Today’s Change
Today|||52-Week Range
Health Technology
Medical Specialties

Company Description

Baxter International, Inc. engages in the provision of a portfolio of essential healthcare products including acute and chronic dialysis therapies, sterile intravenous (IV) solutions, infusion systems and devices, parenteral nutrition therapies, inhaled anesthetics, generic injectable pharmaceuticals, surgical hemostat and sealant products, surgical equipment, smart bed systems, patient monitoring and diagnostic technologies, and respiratory health devices. It operates through the following segments: Americas, Europe, Middle East and Africa (EMEA), Asia-Pacific (APAC), and Hillrom. The Americas, EMEA, and APAC segments offer a portfolio of essential healthcare products. The Hillrom segment provides digital and connected care solutions and collaboration tools, including smart bed systems, patient monitoring and diagnostic technologies, respiratory health devices, and equipment for the surgical space. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL.

Contact Information

Baxter International, Inc.
One Baxter Parkway
Deerfield Illinois 60015-4625
P:(224) 948-2000
Investor Relations:
(224) 948-3020



Individual stakeholders6.65%
Mutual fund holders51.38%
Other institutional36.46%

Top Executives

Joe AlmeidaChairman, President & Chief Executive Officer
Brian C. StevensSenior VP, Chief Financial & Accounting Officer
Paulo Henrique BolgarVice President-Research & Development
Reaz RasulEVP, President-Healthcare Systems & Technologies
Heather KnightEVP, President-Medical Products & Therapies